Conversely, treatment with the PI3K inhibitor LY294002 in the wild type CDDP gastric cancer cells, led to a reduction of phosphorylated PAK4 compared with control cells without affecting total PAK4 expression. The gene discussed is PAK4; the disease is gastric cancer.